Study S001727

A Phase I Clinical Study to Evaluate the Effect of Different Dosing Conditions on the Pharmacokinetics of HRS9531 Tablets in Healthy Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT06506175
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE1
Masking: NONE
Status: NOT_YET_RECRUITING
Enrollment: 100
Start: 2026-07
Primary completion: 2026-09
Lead sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Conditions: Weight Management; Type 2 Diabetes
Interventions: DRUG:HRS9531 tablets
Results posted: FALSE
Individual participant data sharing: UNDECIDED

Registered primary outcomes

AUCtau [0-24 hours after the 10th dosing.]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.